Issue 13, 2016

Preparation of nanosized coacervates of positive and negative starch derivatives intended for pulmonary delivery of proteins

Abstract

Proteins and peptides represent a large fraction of the compounds currently in drug development pipelines. Their application however often depends on the use of carrier systems. Nanoparticles (NPs) are widely used such carrier systems for protein delivery. The aim of this study was to design a new drug delivery system (DDS), prepared under mild conditions in aqueous solution without the requirement of a stabilizer. The biodegradability and biocompatibility of the designed system was explored with a view to specifically determine its potential to facilitate the pulmonary delivery of proteins. As a first step, anionic and cationic water soluble starch-derivatives were synthesized. These starch polymers allowed for NP formation via coacervation, as well as protein loading. Physicochemical characterization of the prepared NPs was then carried out: NPs were found to have a narrow size distribution with an average size ranging from 140 to 350 nm, and a ζ-potential ranging from −10 to −35 mV, depending on the formulation conditions. In a proof of concept study, starch NPs were found to be readily degraded by the human enzyme α-amylase, and showed good biocompatibility with A549 cells after 4 h. Upon nebulization, NPs were seen to be internalized by air–liquid interface cultivated A549 cells as well as 16HBE14o cells. To evaluate the ability of starch NPs to load proteins of various characteristics, NPs were loaded with four model proteins/peptides possessing different molecular weights and isoelectric points – IgG1, RNAse A, insulin, and vancomycin. The greatest loading was achieved in the case of vancomycin with up to 23% drug loading and 43% encapsulation efficiency, indicating an optimal loading of proteins with an isoelectric point close to the pH of the NP suspension. In conclusion, starch NPs prepared by the developed mild and straightforward technique show potential as a safe platform for pulmonary delivery of proteins and peptides.

Graphical abstract: Preparation of nanosized coacervates of positive and negative starch derivatives intended for pulmonary delivery of proteins

Supplementary files

Article information

Article type
Paper
Submitted
20 Jan 2016
Accepted
08 Mar 2016
First published
09 Mar 2016
This article is Open Access
Creative Commons BY-NC license

J. Mater. Chem. B, 2016,4, 2377-2386

Preparation of nanosized coacervates of positive and negative starch derivatives intended for pulmonary delivery of proteins

S. Barthold, S. Kletting, J. Taffner, C. de Souza Carvalho-Wodarz, E. Lepeltier, B. Loretz and C.-M. Lehr, J. Mater. Chem. B, 2016, 4, 2377 DOI: 10.1039/C6TB00178E

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements